Literature DB >> 11243784

Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution.

M P Sebastião1, V Lamzin, M J Saraiva, A M Damas.   

Abstract

Transthyretin (TTR) amyloidosis is a conformational disturbance, which, like other amyloidoses, represents a life threat. Here, we report a TTR variant, TTR Thr119Met, that has been shown to have a protective role in the development of clinical symptoms in carriers of TTR Val30Met, one of the most frequent variants among TTR amyloidosis patients. In order to understand this effect, we have determined the structures of the TTR Val30Met/Thr119Met double mutant isolated from the serum of one patient and of both the native and thyroxine complex of TTR Thr119Met. Major conclusions are: (i) new H-bonds within each monomer and monomer-monomer inter-subunit contacts, e.g. Ser117-Ser117 and Met119-Tyr114, increase protein stability, possibly leading to the protective effect of the TTR Val30Met/Thr119Met variant when compared to the single variant TTR Val30Met. (ii) The mutated residue (Met119) extends across the thyroxine binding channel inducing conformational changes that lead to closer contacts between different dimers within the tetramer. The data, at atomic resolution, were essential to detect, for the first time, the subtle changes in the inter-subunit contacts of TTR, and explain the non-amyloidogenic potential of the TTR Thr119Met variant, improving considerably current research on the TTR amyloid fibril formation pathway. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243784     DOI: 10.1006/jmbi.2000.4415

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  Progress in transthyretin fibrillogenesis research strengthens the amyloid hypothesis.

Authors:  A Chakrabartty
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis.

Authors:  Mark Miller; Arindom Pal; Wabel Albusairi; Hyun Joo; Beverly Pappas; Md Tariqul Haque Tuhin; Dengpan Liang; Raghavendra Jampala; Fang Liu; Jared Khan; Marjon Faaij; Miki Park; William Chan; Isabella Graef; Robert Zamboni; Neil Kumar; Jonathan Fox; Uma Sinha; Mamoun Alhamadsheh
Journal:  J Med Chem       Date:  2018-08-22       Impact factor: 7.446

3.  Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor.

Authors:  Luís Gales; Sandra Macedo-Ribeiro; Gemma Arsequell; Gregorio Valencia; Maria João Saraiva; Ana Margarida Damas
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

4.  Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.

Authors:  Maria Rosário Almeida; Bárbara Macedo; Isabel Cardoso; Isabel Alves; Gregorio Valencia; Gemma Arsequell; Antoni Planas; Maria João Saraiva
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

5.  Amyloidogenic potential of transthyretin variants: insights from structural and computational analyses.

Authors:  Laura Cendron; Antonio Trovato; Flavio Seno; Claudia Folli; Beatrice Alfieri; Giuseppe Zanotti; Rodolfo Berni
Journal:  J Biol Chem       Date:  2009-07-14       Impact factor: 5.157

6.  Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity.

Authors:  Per Hammarström; Xin Jiang; Amy R Hurshman; Evan T Powers; Jeffery W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-25       Impact factor: 11.205

7.  Human embryonic, fetal, and adult hemoglobins have different subunit interface strengths. Correlation with lifespan in the red cell.

Authors:  Lois R Manning; J Eric Russell; Julio C Padovan; Brian T Chait; Anthony Popowicz; Robert S Manning; James M Manning
Journal:  Protein Sci       Date:  2007-08       Impact factor: 6.725

8.  Whole-genome sequence-based analysis of thyroid function.

Authors:  Peter N Taylor; Eleonora Porcu; Shelby Chew; Purdey J Campbell; Michela Traglia; Suzanne J Brown; Benjamin H Mullin; Hashem A Shihab; Josine Min; Klaudia Walter; Yasin Memari; Jie Huang; Michael R Barnes; John P Beilby; Pimphen Charoen; Petr Danecek; Frank Dudbridge; Vincenzo Forgetta; Celia Greenwood; Elin Grundberg; Andrew D Johnson; Jennie Hui; Ee M Lim; Shane McCarthy; Dawn Muddyman; Vijay Panicker; John R B Perry; Jordana T Bell; Wei Yuan; Caroline Relton; Tom Gaunt; David Schlessinger; Goncalo Abecasis; Francesco Cucca; Gabriela L Surdulescu; Wolfram Woltersdorf; Eleftheria Zeggini; Hou-Feng Zheng; Daniela Toniolo; Colin M Dayan; Silvia Naitza; John P Walsh; Tim Spector; George Davey Smith; Richard Durbin; J Brent Richards; Serena Sanna; Nicole Soranzo; Nicholas J Timpson; Scott G Wilson
Journal:  Nat Commun       Date:  2015-03-06       Impact factor: 14.919

9.  Cooperative stabilization of transthyretin by clusterin and diflunisal.

Authors:  Michael J Greene; Elena S Klimtchuk; David C Seldin; John L Berk; Lawreen H Connors
Journal:  Biochemistry       Date:  2014-12-24       Impact factor: 3.162

10.  Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.

Authors:  Teresa Mairal; Joan Nieto; Marta Pinto; Maria Rosário Almeida; Luis Gales; Alfredo Ballesteros; José Barluenga; Juan J Pérez; Jesús T Vázquez; Nuria B Centeno; Maria Joao Saraiva; Ana M Damas; Antoni Planas; Gemma Arsequell; Gregorio Valencia
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.